Every Family Begins with Healthy Sperm
iPreg Inc. is a Taiwan-based biotechnology company specialising in microfluidic cell separation technology for assisted reproduction. Founded in 2018, the company has developed the SperŜort™ platform — a patented sperm sorting biochip system designed to improve the quality of sperm used in IVF and ICSI procedures.
Male infertility is a significant contributor to infertility in couples. Conventional sperm preparation by centrifugation can damage sperm DNA, negatively affecting reproductive outcomes. The SperŜort™ system addresses this by using microfluidic principles — including rheotaxis, chemotaxis, and thermotaxis — to passively sort highly motile, morphologically normal sperm without any centrifugation or antibody labelling.
iPreg Inc. holds 6 patents in the USA and Taiwan, and has developed a complete product range including the SperŜort™ Biochip, SperŜort™ Hatcher, and SperŜort™ Station for clinic use. In 2024, the company secured TFDA (Taiwan Food and Drug Administration) certification for its devices, and is progressing toward US FDA 510(k) clearance. Advanced Biotech Pty Ltd is the prospective Australian distributor — products are not yet available in Australia.
SperŜort™ Platform
The complete iPreg SperŜort™ system — from single-use sorting biochip to integrated clinic station. Contact Advanced Biotech to register interest in Australian availability.
SperŜort™ Biochip
Patented microfluidic sperm sorting chip for passive selection of highly motile, morphologically normal sperm with intact DNA from unprocessed semen. No centrifugation required. Suitable for IVF and ICSI preparation.
Learn more
SperŜort™ Hatcher
The SperŜort™ Hatcher is designed to work with the biochip, providing controlled conditions for the sperm sorting process. Supports consistent, reproducible sperm preparation across IVF laboratory workflows.
Learn more
SperŜort™ Station
The complete integrated SperŜort™ Station for clinical IVF laboratory use. Combines the biochip and hatcher into a streamlined workstation for routine sperm preparation in assisted reproduction.
Learn moreWhy SperŜort™
The SperŜort™ platform replicates natural cellular environments using microfluidic principles — selecting the best sperm without damaging centrifugation or antibody labelling.
DNA Integrity Preserved
Conventional centrifugation can fragment sperm DNA. SperŜort™ selects sperm without centrifugation, preserving DNA integrity for improved embryo quality and IVF outcomes.
Fast — 30 Minutes
The entire sorting process completes within 30 minutes. Progressive sperm ratio increases to 90% — ready for immediate use in IVF or ICSI procedures.
No Equipment Needed
The SperŜort™ Biochip operates without centrifuges or additional instrumentation. Simple procedure with consistent, reproducible results for IVF laboratory workflows.
Morphology & Motility
Simultaneous selection for intact morphology, superior motility, and DNA quality — selecting sperm that most closely mirrors natural fertilisation conditions.
IVF & ICSI Suitable
Validated for use in both standard in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI) treatment cycles.
6 Patents + TFDA Certified
6 patents in the USA and Taiwan. TFDA (Taiwan FDA) device certification secured in 2024. US FDA 510(k) clearance in progress.
Microfluidic Cell Separation Principle
The SperŜort™ platform is built on iPreg's proprietary microfluidic cell separation technology. Using principles from fluid mechanics, microfluidics, rheotaxis, chemotaxis, and thermotaxis, the biochip is engineered for antibody-free selection and purification of sperm cells. This methodology replicates natural cellular environments, optimising both viability and functionality.
Sperm sorted by SperŜort™ demonstrate superior motility, morphology, and DNA integrity compared to conventional centrifugation preparation. The patented microfluidic sperm sorting chip enables separation of the most motile sperm from unprocessed semen — directly suitable for ICSI injection without further processing.
Beyond assisted reproduction, iPreg's core technology has broader applications in oncology (tumour cell isolation) and regenerative medicine (stem cell selection).
Patent 11,491,488 B2 — Sperm Sorting Chip & Method
Patent 17/835,626 — Vertical Thermal Gradient Equipment
Patent I684753 — Sperm Sorting Chip
Patent I778747 — Sperm Sorting Device
Patent M588247 — Sperm Sorting Microfluidic Chip
Patent M629492 — Sperm Sorting Microfluidic Chip
Register Your Interest — iPreg Inc. in Australia
iPreg Inc. SperŜort™ products are not yet available in Australia. Contact Advanced Biotech Pty Ltd to register your interest and be notified when products become available.